Pall has a mature Business Continuity Management System, as well as a strong global and local infrastructure, to ensure minimal disruption to our business. In addition, Pall has implemented a comprehensive COVID-19 Pandemic Response Plan to minimize any impact to our customers, while protecting our associates and communities.
Pall prioritizes our associates’ health and well-being, as they safely work to manufacture and deliver essential products and services to customers. We take measures to prevent the spread of COVID-19 at our sites and promote social distancing.
Pall is participating in a consortium led by the Jenner Institute, University of Oxford (Oxford, England), to rapidly develop, scale-up and produce a vaccine for COVID-19. As part of the consortium, Pall will develop a large-scale manufacturing process, so that millions of doses of a vaccine can be produced. You can learn more here: Pall Corporation Participates In A Consortium To Rapidly Develop A COVID-19 Vaccine.
Need Immediate Assistance ?
Need Product Information ?
Product Specific frequently asked questions can be found on the product page. Please use the navigation, search bar or click below to help navigate to our products.